Persistent Microbial Translocation and Immune Activation in HIV‐1–Infected South Africans Receiving Combination Antiretroviral Therapy
The Journal of Infectious Diseases2010Vol. 202(5), pp. 723–733
Citations Over TimeTop 10% of 2010 papers
Edana Cassol, Susan Malfeld, Phetole Walter Mahasha, Van der Merwe, Sharon Cassol, Christopher J. Seebregts, Massimo Alfano, Guido Poli, Theresa M. Rossouw
Abstract
Microbial translocation is a major force driving chronic inflammation in HIV-infected Africans receiving cART. Prevention of monocyte activation may be especially effective at enhancing therapeutic outcomes.
Related Papers
- → Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients(2008)138 cited
- → Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir(2019)16 cited
- → The CD14++CD16+ monocyte subset is expanded and controls Th1 cell development in Graves' disease(2022)15 cited
- → Microinflammation in hemodialysis is related to a preactivated subset of monocytes(2006)31 cited
- → Human monocyte heterogeneity–a nephrological perspective(2010)13 cited